CAS 532414-36-1

Formoterol Related Compound I (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide)

CAS : 532414-36-1

Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof

Formule : C₁₉H₂₄N₂O₄

Couleur et forme : Off-White Solid

Masse moléculaire : 344.17361

Ref: 45-1286184

Formoterol EP Impurity I-13C-d3

CAS : 532414-36-1

Formule : C₁₈₁₃CH₂₁D₃N₂O₄

Masse moléculaire : 348.42

Ref: 4Z-F-11103

Formoterol EP Impurity I (Formoterol USP Related Compound I)

CAS : 532414-36-1

Formule : C₁₉H₂₄N₂O₄

Couleur et forme : White To Off-White Solid

Masse moléculaire : 344.41

Ref: 4Z-F-1118

Formoterol EP Impurity I

CAS : 532414-36-1

Formule : C₁₉H₂₄N₂O₄

Masse moléculaire : 344.41

Ref: ST-EA-CP-F42058

rel-(R,S)-Formoterol

CAS : 532414-36-1

Applications rel-(R,S)-Formoterol is a stereoisomer of Formoterol (F693395). Formoterol is a long-acting inhaled beta-2 agonist (bronchodilator) that is used to treat patients with COPD and asthma.
References Cazzola, M., et al.: CHEST J., 114, 411 (1998); Kips, J., et al.: Am. J. Resp. Crit. Care Med., 161, 996 (2000); O’Byrne, P., et al.: Am. J. Rest. Crit. Care Med., 164, 1392 (2001)

Formule : C₁₉H₂₄N₂O₄

Couleur et forme : Neat

Masse moléculaire : 344.405

Ref: TR-F693435

Rel-(R,S)-formoterol

Produit contrôlé

CAS : 532414-36-1

Rel-(R,S)-formoterol is a medicinal compound that has shown promising results in the inhibition of cancer cell growth. It is derived from Chinese medicinal plants and has been tested on human cancer cell lines. Rel-(R,S)-formoterol works by inhibiting kinase activity, which is involved in regulating the cell cycle and preventing apoptosis. By inhibiting this activity, Rel-(R,S)-formoterol induces apoptosis and leads to cell death in cancer cells. This compound also acts as a protein inhibitor, preventing the formation of protein complexes that are essential for cancer cell survival. In addition, Rel-(R,S)-formoterol has been detected in urine samples of patients undergoing cancer treatment, indicating its potential use as a therapeutic agent.

Formule : C₁₉H₂₄N₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 344.4 g/mol

Ref: 3D-HWA41436